153 related articles for article (PubMed ID: 24133142)
1. Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer.
Podust VN; Sim BC; Kothari D; Henthorn L; Gu C; Wang CW; McLaughlin B; Schellenberger V
Protein Eng Des Sel; 2013 Nov; 26(11):743-53. PubMed ID: 24133142
[TBL] [Abstract][Full Text] [Related]
2. Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility.
Ding S; Song M; Sim BC; Gu C; Podust VN; Wang CW; McLaughlin B; Shah TP; Lax R; Gast R; Sharan R; Vasek A; Hartman MA; Deniston C; Srinivas P; Schellenberger V
Bioconjug Chem; 2014 Jul; 25(7):1351-9. PubMed ID: 24932887
[TBL] [Abstract][Full Text] [Related]
3. GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model.
Alters SE; McLaughlin B; Spink B; Lachinyan T; Wang CW; Podust V; Schellenberger V; Stemmer WP
PLoS One; 2012; 7(11):e50630. PubMed ID: 23189208
[TBL] [Abstract][Full Text] [Related]
4. Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.
Podust VN; Balan S; Sim BC; Coyle MP; Ernst U; Peters RT; Schellenberger V
J Control Release; 2016 Oct; 240():52-66. PubMed ID: 26497931
[TBL] [Abstract][Full Text] [Related]
5. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
[TBL] [Abstract][Full Text] [Related]
6. Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer.
Huang YS; Wen XF; Wu YL; Wang YF; Fan M; Yang ZY; Liu W; Zhou LF
Eur J Pharm Biopharm; 2010 Mar; 74(3):435-41. PubMed ID: 19995603
[TBL] [Abstract][Full Text] [Related]
7. GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630.
Alters SE; McLaughlin B; Spink B; Lachinyan T; Wang CW; Podust V; Schellenberger V; Stemmer WP
PLoS One; 2013; 8(6):. PubMed ID: 23762221
[TBL] [Abstract][Full Text] [Related]
8. Expression, Purification, and Biological Evaluation of XTEN-GCSF in a Neutropenic Rat Model.
Nikravesh FY; Gholami P; Bayat E; Talebkhan Y; Mirabzadeh E; Damough S; Aliabadi HAM; Nematollahi L; Ardakani YH
Appl Biochem Biotechnol; 2024 Feb; 196(2):804-820. PubMed ID: 37209276
[TBL] [Abstract][Full Text] [Related]
9. Studies of poly(ethylene glycol) modification of HM-3 polypeptides.
Zhou K; Zheng X; Xu HM; Zhang J; Chen Y; Xi T; Feng T
Bioconjug Chem; 2009 May; 20(5):932-6. PubMed ID: 19413309
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of minor metabolites and pharmacokinetics of ganoderic acid C2 in rat plasma by HPLC coupled with electrospray ionization tandem mass spectrometry.
Guo XY; Liu D; Ye M; Han J; Deng S; Ma XC; Zhao Y; Zhang B; Shen X; Che QM
J Pharm Biomed Anal; 2013 Mar; 75():64-73. PubMed ID: 23312386
[TBL] [Abstract][Full Text] [Related]
11. A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner.
Schellenberger V; Wang CW; Geething NC; Spink BJ; Campbell A; To W; Scholle MD; Yin Y; Yao Y; Bogin O; Cleland JL; Silverman J; Stemmer WP
Nat Biotechnol; 2009 Dec; 27(12):1186-90. PubMed ID: 19915550
[TBL] [Abstract][Full Text] [Related]
12. Characterization of amyloid formation by glucagon-like peptides: role of basic residues in heparin-mediated aggregation.
Jha NN; Anoop A; Ranganathan S; Mohite GM; Padinhateeri R; Maji SK
Biochemistry; 2013 Dec; 52(49):8800-10. PubMed ID: 24236650
[TBL] [Abstract][Full Text] [Related]
13. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein.
Kochendoerfer GG; Chen SY; Mao F; Cressman S; Traviglia S; Shao H; Hunter CL; Low DW; Cagle EN; Carnevali M; Gueriguian V; Keogh PJ; Porter H; Stratton SM; Wiedeke MC; Wilken J; Tang J; Levy JJ; Miranda LP; Crnogorac MM; Kalbag S; Botti P; Schindler-Horvat J; Savatski L; Adamson JW; Kung A; Kent SB; Bradburne JA
Science; 2003 Feb; 299(5608):884-7. PubMed ID: 12574628
[TBL] [Abstract][Full Text] [Related]
14. Chemical macrocyclization of peptides fused to antibody Fc fragments.
Angelini A; Diderich P; Morales-Sanfrutos J; Thurnheer S; Hacker D; Menin L; Heinis C
Bioconjug Chem; 2012 Sep; 23(9):1856-63. PubMed ID: 22812498
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
16. Challenges in the delivery of peptide drugs: an industry perspective.
Lewis AL; Richard J
Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
[TBL] [Abstract][Full Text] [Related]
17. Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.
Zhang J; Bodenko V; Larkina M; Bezverkhniaia E; Xu T; Liao Y; Abouzayed A; Plotnikov E; Tretyakova M; Yuldasheva F; Belousov MV; Orlova A; Tolmachev V; Gräslund T; Vorobyeva A
J Control Release; 2024 Jun; 370():468-478. PubMed ID: 38697314
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
[TBL] [Abstract][Full Text] [Related]
19. Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose.
Geething NC; To W; Spink BJ; Scholle MD; Wang CW; Yin Y; Yao Y; Schellenberger V; Cleland JL; Stemmer WP; Silverman J
PLoS One; 2010 Apr; 5(4):e10175. PubMed ID: 20418955
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma.
Ghobrial OG; Derendorf H; Hillman JD
J Pharm Biomed Anal; 2009 May; 49(4):970-5. PubMed ID: 19269770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
